Monsanto closes $300M sale of cow growth hormone brand

10/2/2008 | Forbes

Monsanto has finalized the $300 million sale of Posilac, a cow growth hormone brand, to Eli Lilly and Co. The transaction is in line with Monsanto's long-term plan to concentrate on marketing high-tech seeds to farmers throughout the world.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX